Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00334 |
| Species: | Homo sapiens |
| Position : | chr5:149631000-149636000 |
| Year: | 2021 |
| Title: | TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | breast carcinoma |
| PMID: | 34718356 |
| MONDO: | MONDO:0006120 |
| Tissue: | Breast |
| Tissue Ontology ID: | UBERON:0000310 |
| Cell Source: | Human breast cancer cell |
| CVCL ID: | |
| Cell Type: | breast carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq, DNase-seq |
| Low Throughput Method: | Luciferase Reporter Assay, ChIP-RT-qPCR, CRISPR knockout, RT-RT-qPCR, Western blot |
| Target gene : | TCOF1 |
| TF name : | YY1; MYBL2; PLAG1; FOSL1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|